@mtbendermdi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Cerebrovascular neurosurgeon @UofR / alumnus @hopkinsnsurg @mckinsey @yale / @ironmantri triathlete, marathoner, run commuter
Rochester, NY
Joined September 2022
- Tweets613
- Following677
- Followers1.4K
- Likes2K
Matt Bender retweeted
Seeing some great new studies for the first issue of JNIS Advances, from stroke to surgery and from new devices to outcome prediction. Submit your work now for rapid, expert peer review and a chance to be included in vol. 1 no. 1! jnisadvances.bmj.com/pages/a… @SNISinfo @JNIS_BMJ
Matt Bender retweeted
This journal would not be possible without an incredible editorial board (tinyurl.com/5dv9thvt). International talent from all aspects of neurointervention. @mtbendermd @MattAmansMD @JAGrossbergMD @MajidiShahram #DanRaper @slater_leeanne
Matt Bender retweeted
Endovascular Treatment of Medium-Vessel-Occlusion Strokes | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
IT cardene works best when started before any sign of ischemia in aneurysmal SAH @URNeurosurgery @URNeuroscience
🚨 New study in Clinical Neurology and Neurosurgery on aneurysmal subarachnoid hemorrhage (aSAH) management 🩸 🧠
Anticipatory initiation of Intrathecal Nicardipine (ITN)—given before clinical or imaging evidence of delayed cerebral ischemia (DCI)—significantly reduces DCI parenchymal infarcts compared to controls (31.3% vs 55.2%).
Key findings:
📉 Starting ITN prior to intra-arterial (IA) spasmolytics significantly lowers the need for serial IA treatments for recalcitrant vasospasm from 71.4% down to 23.1%.
🛡️ It is a safe intervention with no increased risk of EVD-related complications or meningitis.
⚠️ Timing is everything, because reactionary ITN given after DCI onset did not reduce the rate of additional infarcts or the need for serial IA treatments.
Question: Does this article change your practice?
#NeuroTwitter #NeuroCriticalCare #SubarachnoidHemorrhage #Vasospasm #NeuroSurgery
sciencedirect.com/science/ar…
Matt Bender retweeted
Save the date! Inaugural meeting of the International Society for Spinal CSF leak in New York City, New York, October 17&18, 2026. @spinalCSFleak @csfleakuk @SpinalCSFLeakAu @SpinalCSFCanada @issclsociety @PeterGKranz
Matt Bender retweeted
Kicking off day 3 of the 2026 #cerebralvenous & #CSF Disorders Summit with @mtbendermd and Emanuele Orru’, MD 📝
Skills lab today @URNeurosurgery simulating type 2 and 3 CSF leak repair. Seeing more and more of these cases. Great to practice and teach technique. Appreciate educational grant support from @BioventusGlobal for bone scalpel laminoplasty. @spinalCSFleak
Such a treat to visit and share my experience treating patients with spontaneous intracranial hypotension. Clever residents and inspiring faculty! @spinalCSFleak @URNeurosurgery
We are honored to welcome Matthew T. Bender, M.D., from @URNeurosurgery, as our Invited Visiting Professor! Join us as we host Dr. Bender for an insightful session sharing his expertise in neurosurgery and patient care. #VisitingProfessor #WakeForestNeurosurg
What is the inciting insult in #IIH? We’ve argued it’s glymphedema and interstitial fluid accumulation. Excited to see this come out in @HeadacheJournal
@URNeuroscience @URNeurosurgery
🧠 New narrative review: A proposed disease model for #IIH suggests altered brain fluid regulation, linked to obesity, may drive a cycle of fluid buildup, venous compression, & ⬆️intracranial pressure.
Read the full article: headachejournal.onlinelibrar…
@D_SchartzMD @mtbendermd
Matt Bender retweeted
After two years and thousands of manuscripts, I’ve learned that the real work of an editor isn’t gatekeeping — it’s partnership.
My latest @JACCJournals Editor’s Page: The Partnership
🔗 jacc.org/doi/10.1016/j.jacc.…
#MedTwitter #AcademicMedicine #Cardiology @YaleMed @YaleSPH
Matt Bender retweeted
Congrats to @AaronAnandaraj1 one of our most productive @penn undergraduates in the #NeuroVERT lab, now a med student up in Rochester.
Look forward to following your work with @mtbendermd and crew – at Philadelphia, PA
Fun seeing friends and collaborators at @UofLNeurosurg while sharing research on neutrophil extracellular traps and complement proteins in ischemic stroke thrombus @URNeurosurgery
Matt Bender retweeted
Congratulations to our resident, @SajalAkkipeddi, postdoctoral fellow, @SantiMendozAyus, and medical students, @HermnLi and Arul Malhotra, for presenting at CNS! 🧠
#CNS2025 #Neurosurgery #URochesterResearch #Match2026 #NeuroTwitter #MedEd
Matt Bender retweeted
thejns.org/view/journals/j-n…
Thrilled to show our findings implicating the glymphatic system in futile recanalization after thrombectomy in LVO #stroke. Is the glymphatic system a potential therapeutic target? @mtbendermd
Matt Bender retweeted
Interesting analysis from RESCU ICAS led by @mtbendermd . Worse NIHSS on presentation and higher number of passes are strong predictors for futile recanalization, while stenting and complete recan provide protective effect
…and there are consistent molecular patterns found in thrombi from patients with post-thrombectomy hemorrhage. More to come from @URNeurosurgery @SajalAkkipeddi
Asymptomatic Hemorrhagic Transformation After Thrombectomy
Is associated with substantially worse clinical outcomes
neurology.org/doi/10.1212/CP…
Matt Bender retweeted
Navin had trouble walking, remembering, and needed help with daily tasks—signs of normal pressure hydrocephalus (NPH), caused by fluid buildup in the brain.
A new study helped treat his condition without major surgery. Now he walks 3–4 miles a day! #URochesterResearch
Proud of @URNeurosurgery residents and fellows presenting our department’s work on ischemic and hemorrhagic stroke at #SNIS2025 @SNISinfo @URochester_SMD
Shared our progress searching for a plasma biomarker of stroke thrombus NETs at #SNIS2025.
Grateful for support of @SNISinfo and @joeniekro. @SajalAkkipeddi @URNeurosurgery